Inventor · disambiguated record
Billie M. York, Jr.
Also filed as: YORK BILLIE M · YORK JR BILLIE M
31 granted patents·1 pending application·1,123 citations·filing 1981–2001
98Inventor score
Top patents by PatentIndex Score
32 records- 0197US6316441B1Brinzolamide and brimonidine for treating glaucomaALCON MFG LTD·Filed 2001·Granted Nov 13, 2001·85 cites·2 claims
- 0297US4436745AMethod of inhibiting aldose reductase activityALCON LAB INC·Filed 1982·Granted Mar 13, 1984·56 cites·18 claims
- 0396US4438272ASpiro-(fluoren-9,4'-imidazolidine)-2',5'-dionesALCON LAB INC·Filed 1982·Granted Mar 20, 1984·42 cites·14 claims
- 0493US4517199AMethod for lowering intraocular pressure using phenylimino-imidazolesALCON LAB INC·Filed 1983·Granted May 14, 1985·29 cites·14 claims
- 0592US4515800AMethod of lowering intraocular pressure using phenylimino-imidazolesCAVERO ICILIO·Filed 1983·Granted May 7, 1985·44 cites·3 claims
- 0691US6413245B1Sub-tenon drug deliveryALCON UNIVERSAL LTD·Filed 2000·Granted Jul 2, 2002·306 cites·36 claims
- 0791US6242442B1Brinzolamide and brimonidine for treating ocular conditionsALCON LAB INC·Filed 1999·Granted Jun 5, 2001·86 cites·4 claims
- 0891US4755528AHigh energy ionizing protective 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereof, compositions and method of use thereforALCON LAB INC·Filed 1987·Granted Jul 5, 1988·36 cites·13 claims
- 0987US4864028ASpiro-tricyclicaromatic succinimide derivativesALCON LAB INC·Filed 1987·Granted Sep 5, 1989·21 cites·20 claims
- 1085US4587257AControl of ocular bleeding using clonidine derivativesALCON LAB INC·Filed 1984·Granted May 6, 1986·63 cites·21 claims
- 1185US4461904A2-(Trisubstituted phenylimino)-imidazolinesALCON LAB INC·Filed 1981·Granted Jul 24, 1984·28 cites·10 claims
- 1282US4659733AMethod for treating hypertension with 2,3-diamino-1,4-butanedithiol; 4,5-diamino-1,2-dithiane; and N-acyl and N-alkyl derivatives thereofALCON LAB INC·Filed 1984·Granted Apr 21, 1987·14 cites·7 claims
- 1381US5153211ASpiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductaseALCON LAB INC·Filed 1991·Granted Oct 6, 1992·20 cites·7 claims
- 1480US5314916AB2 adrenegic agonists and use thereof in the treatment of glaucomaALCON LAB INC·Filed 1993·Granted May 24, 1994·20 cites·9 claims
- 1577US4537892ASpiro-tricyclicaromatic succinimide derivatives as inhibitors of aldose reductaseALCON LAB INC·Filed 1983·Granted Aug 27, 1985·16 cites·72 claims
- 1675US5612364ASubstantially pure apraclonidineALCON LAB INC·Filed 1995·Granted Mar 18, 1997·18 cites·4 claims
- 1771US5070100ASpiro-tricyclicaromatic succinimide derivativesALCON LAB INC·Filed 1989·Granted Dec 3, 1991·8 cites·13 claims
- 1869US5212196AControl of post-surgical intraocular pressure using clonidine derivativesALCON LAB INC·Filed 1992·Granted May 18, 1993·46 cites·22 claims
- 1968US4644007A3-chloro-4-(4,5-dihydro-1H-imidazo-2-yl)-amino-5-alkylbenzoic acids, esters, salts, compositions and methodsALCON LAB INC·Filed 1985·Granted Feb 17, 1987·7 cites·14 claims
- 2067US5192780AMethods using antiallergics and antihistaminesALCON LAB INC·Filed 1991·Granted Mar 9, 1993·32 cites·4 claims
- 2166US4540700ATreatment of diabetic complications with certain spiro-imidazolidine-dionesALCON LAB INC·Filed 1984·Granted Sep 10, 1985·5 cites·2 claims
- 2264US5696091AUse of growth factor and antimetabolite combination to prevent or retard secondary cataract formationALCON LAB INC·Filed 1996·Granted Dec 9, 1997·25 cites·12 claims
- 2364US4600717AAldose reductase inhibitors useful in ophthalmic wound healingALCON LAB INC·Filed 1984·Granted Jul 15, 1986·22 cites·3 claims
- 2463US4717725AOphthalmic wound healing with aldose reductase inhibitorsALCON LAB INC·Filed 1986·Granted Jan 5, 1988·26 cites·8 claims
- 2556US5411940AUse of TGF-β3 to reduce the formation of scar tissue in response to corneal traumaALCON LAB INC·Filed 1993·Granted May 2, 1995·18 cites·7 claims
- 2655US5976462ACompositions and method for disinfecting fabricFiled 1997·Granted Nov 2, 1999·10 cites·4 claims
- 2755US4609663AAldose reductase inhibitors useful in glaucoma therapyALCON LAB INC·Filed 1984·Granted Sep 2, 1986·13 cites·8 claims
- 2853US5521208ACompositions and methods for the treatment of the metabolically impaired and for improved complianceALCON LAB INC·Filed 1993·Granted May 28, 1996·16 cites·18 claims
- 2947US2002016359A1Compositions and methods of treating neurodegenerative diseasesFiled 2001·Application pending·0 cites
- 3041US5714463AUse of growth factor and antimetabolite combination to prevent or retard fistula closure following glaucoma filtration surgeryALCON LAB INC·Filed 1995·Granted Feb 3, 1998·4 cites·7 claims
- 3141US4464385ATreatment of diabetic complications with hydantoinsALCON LAB INC·Filed 1982·Granted Aug 7, 1984·1 cites·4 claims
- 3239US5449671AUse of TGF-β3, to prevent or retard fistula closure following glaucoma filtration surgeryALCON LAB INC·Filed 1993·Granted Sep 12, 1995·6 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Billie M. York, Jr. files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →